Veenendaal J R, Edstein M D, Rieckmann K H
Army Malaria Research Unit, Milpo, Ingleburn, Australia.
Chemotherapy. 1988;34(4):275-83.
The pharmacokinetic parameters of chlorproguanil (Lapudrine) and its active metabolite, chlorcycloguanil, were determined in 6 healthy male volunteers after a single oral dose of 4 Lapudrine tables (80 mg). The mean maximum plasma chlorproguanil concentration was 36.7 +/- (SD) 7.9 ng/ml and was reached at 3.8 +/- 1.3 h. The chlorproguanil elimination half-life was 17.5 +/- 6.7 h and its plasma clearance was 1.28 +/- 0.12 l/h/kg. The mean whole blood to plasma ratio was 3.1 at 4 h after dosing. Chlorcycloguanil could not be quantified in plasma and whole blood at the detection limit of 10 ng/ml using a high-performance liquid chromatographic method. An excretion rate-time plot from urine data shows a rapid (t1/2 = 20 h) and a slow phase (t1/2 = 51 h) in the elimination of chlorcycloguanil. Our findings suggest that the current prophylactic regimen of chlorproguanil hydrochloride (20 mg weekly) may not be optimal in preventing infections with chloroquine-resistant falciparum malaria.
在6名健康男性志愿者单次口服4片氯胍(Lapudrine,80毫克)后,测定了氯胍及其活性代谢物环氯胍的药代动力学参数。氯胍的平均血浆最大浓度为36.7±(标准差)7.9纳克/毫升,在3.8±1.3小时达到。氯胍的消除半衰期为17.5±6.7小时,其血浆清除率为1.28±0.12升/小时/千克。给药后4小时全血与血浆的平均比值为3.1。使用高效液相色谱法在10纳克/毫升的检测限下,血浆和全血中的环氯胍无法定量。根据尿液数据绘制的排泄速率-时间图显示,环氯胍的消除存在快速相(t1/2 = 20小时)和缓慢相(t1/2 = 51小时)。我们的研究结果表明,当前盐酸氯胍(每周20毫克)的预防方案在预防耐氯喹恶性疟感染方面可能并非最佳。